XORTX Therapeutics Inc. (TSXV:XRTX)
Canada · Delayed Price · Currency is CAD 0.5700
-0.0100 (-1.72%)
Feb 9, 2026, 3:55 PM EST
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
3.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - | 2 | 1 |
| Dec 31, 2022 | 3 | 0 | - | 3 | 0 |
| Jan 1, 2022 | 3 | - | - | 3 | 0 |
XORTX Therapeutics News
- 5 days ago - Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket - Benzinga
- 5 days ago - XORTX Extends Closing Of Renal Anti-Fibrotic Therapeutic Program Acquisition; Stock Soars - Nasdaq
- 4 months ago - XORTX Announces Pricing of US$1.1 Million Registered Direct Offering - GlobeNewsWire
- 4 months ago - XORTX Therapeutics (XRTX) Secures Nasdaq Extension to Meet Bid Price Rule - GuruFocus
- 4 months ago - XORTX Therapeutics gains 180-day extension from Nasdaq to regain $1.00 bid price compliance - Seeking Alpha
- 4 months ago - XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency - GlobeNewsWire
- 4 months ago - XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 4 months ago - XORTX (XRTX) Acquires Renal Therapeutic Program from Vectus - GuruFocus